Jan Willem Nieuwenhuize
Private Equity Investor bij ING Corporate Investments BV
Profiel
Jan Willem Nieuwenhuize is currently the Managing Director at ING Corporate Investments BV since 2017.
Previously, he worked as a Director at Agendia, Inc. and as a Member-Supervisory Board at Agendia NV.
Actieve functies van Jan Willem Nieuwenhuize
| Bedrijven | Functie | Begin |
|---|---|---|
ING Corporate Investments BV
 ING Corporate Investments BV Investment ManagersFinance ING Corporate Investments BV is a Private Equity/Venture Capital firm, a subsidiary of ING Groep NV founded in 1990. ING Corporate Investments BV is headquartered in Amsterdam. | Private Equity Investor | 01-06-2007 |
Eerdere bekende functies van Jan Willem Nieuwenhuize
| Bedrijven | Functie | Einde |
|---|---|---|
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Directeur/Bestuurslid | - |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Health Services |
ING Corporate Investments BV
ING Corporate Investments BV Investment ManagersFinance ING Corporate Investments BV is a Private Equity/Venture Capital firm, a subsidiary of ING Groep NV founded in 1990. ING Corporate Investments BV is headquartered in Amsterdam. | Finance |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
